AngioDynamics Inc. (ANGO)
| Bid | 8.83 |
| Market Cap | 372.57M |
| Revenue (ttm) | 283.32M |
| Net Income (ttm) | -41.39M |
| EPS (ttm) | -1.01 |
| PE Ratio (ttm) | -9.08 |
| Forward PE | -44.21 |
| Analyst | Strong Buy |
| Ask | 10.48 |
| Volume | 241,781 |
| Avg. Volume (20D) | 520,457 |
| Open | 9.27 |
| Previous Close | 9.29 |
| Day's Range | 8.96 - 9.21 |
| 52-Week Range | 5.47 - 13.50 |
| Beta | 0.52 |
About ANGO
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequ...
Analyst Forecast
According to 2 analyst ratings, the average rating for ANGO stock is "Strong Buy." The 12-month stock price forecast is $14, which is an increase of 52.59% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago · https://thefly.com
AngioDynamics price target raised to $16 from $15 at H.C. WainwrightH.C. Wainwright raised the firm's price target on AngioDynamics to $16 from $15 and keeps a Buy rating on the shares. The company reported a beat in fiscal Q3 and raised its fiscal 2025 guidance, the ...
1 month ago · businesswire.com
AngioDynamics Reports Fiscal Year 2025 Third Quarter Financial ResultsLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expand...
